U.S. Senator Sinema, House Speaker Pelosi spoke on prescription drug prices - CNN
Reuters
Published Nov 01, 2021 11:40AM ET
(Reuters) - Centrist Democratic Senator Kyrsten Sinema and U.S. House of Representatives Speaker Nancy Pelosi spoke over the weekend on the issue of prescription drug prices, CNN reported on Monday.
Progressive (NYSE:PGR) Senator Bernie Sanders said on Sunday he was working on getting a provision to lower prescription drug prices into the $1.75 trillion social spending bill pending in the U.S. Congress before a vote by the House.
The proposal that would allow the U.S. government's Medicare health plan for seniors to negotiate cheaper prices for prescription medicines was not included in the social spending bill.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.